Annual ROE
-29.98%
-6.55%-27.96%
December 31, 2023
Summary
- As of February 7, 2025, ATXS annual return on equity is -29.98%, with the most recent change of -6.55% (-27.96%) on December 31, 2023.
- During the last 3 years, ATXS annual ROE has risen by +61.74% (+67.31%).
- ATXS annual ROE is now -186.35% below its all-time high of 34.72%, reached on December 31, 2013.
Performance
ATXS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-30.79%
+1.86%+5.70%
September 30, 2024
Summary
- As of February 7, 2025, ATXS quarterly return on equity is -30.79%, with the most recent change of +1.86% (+5.70%) on September 30, 2024.
- Over the past year, ATXS quarterly ROE has dropped by -4.00% (-14.93%).
- ATXS quarterly ROE is now -138.35% below its all-time high of 80.29%, reached on March 31, 2015.
Performance
ATXS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ATXS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.0% | -14.9% |
| 3 y3 years | +67.3% | -14.9% |
| 5 y5 years | +59.5% | -14.9% |
ATXS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -28.0% | +81.2% | -17.1% | +88.6% |
| 5 y | 5-year | -28.0% | +81.2% | -17.1% | +98.5% |
| alltime | all time | -186.3% | +81.2% | -138.3% | +98.5% |
Astria Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -30.79%(-5.7%) |
| Jun 2024 | - | -32.65%(-0.4%) |
| Mar 2024 | - | -32.79%(-5.6%) |
| Dec 2023 | -29.98%(+28.0%) | -34.74%(+29.7%) |
| Sep 2023 | - | -26.79%(+1.9%) |
| Jun 2023 | - | -26.29%(-11.2%) |
| Mar 2023 | - | -29.59%(-22.5%) |
| Dec 2022 | -23.43%(-85.3%) | -38.17%(-11.8%) |
| Sep 2022 | - | -43.27%(+13.7%) |
| Jun 2022 | - | -38.05%(+18.3%) |
| Mar 2022 | - | -32.16%(-88.1%) |
| Dec 2021 | -159.36%(+73.7%) | -270.25%(-28.1%) |
| Sep 2021 | - | -375.92%(-40.1%) |
| Jun 2021 | - | -627.96%(-68.8%) |
| Mar 2021 | - | -2009.64%(+2520.5%) |
| Dec 2020 | -91.72%(+24.6%) | -76.69%(+4.1%) |
| Sep 2020 | - | -73.70%(+7.6%) |
| Jun 2020 | - | -68.51%(+3.9%) |
| Mar 2020 | - | -65.96%(+4.9%) |
| Dec 2019 | -73.61% | -62.89%(+1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -61.87%(+4.8%) |
| Jun 2019 | - | -59.06%(+4.2%) |
| Mar 2019 | - | -56.69%(-26.5%) |
| Dec 2018 | -74.04%(-44.7%) | -77.11%(-15.4%) |
| Sep 2018 | - | -91.15%(-26.3%) |
| Jun 2018 | - | -123.65%(-29.5%) |
| Mar 2018 | - | -175.29%(+16.8%) |
| Dec 2017 | -133.88%(+8.0%) | -150.03%(+10.5%) |
| Sep 2017 | - | -135.83%(+18.1%) |
| Jun 2017 | - | -115.02%(+2.2%) |
| Mar 2017 | - | -112.51%(+9.6%) |
| Dec 2016 | -123.98%(+91.9%) | -102.67%(+12.7%) |
| Sep 2016 | - | -91.14%(+13.8%) |
| Jun 2016 | - | -80.08%(+23.5%) |
| Mar 2016 | - | -64.82%(-5.1%) |
| Dec 2015 | -64.62%(-315.7%) | -68.30%(-60.3%) |
| Sep 2015 | - | -171.98%(-82.7%) |
| Jun 2015 | - | -994.39%(-1338.5%) |
| Mar 2015 | - | 80.29%(+168.1%) |
| Dec 2014 | 29.96%(-13.7%) | 29.95% |
| Dec 2013 | 34.72% | - |
FAQ
- What is Astria Therapeutics annual return on equity?
- What is the all time high annual ROE for Astria Therapeutics?
- What is Astria Therapeutics annual ROE year-on-year change?
- What is Astria Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Astria Therapeutics?
- What is Astria Therapeutics quarterly ROE year-on-year change?
What is Astria Therapeutics annual return on equity?
The current annual ROE of ATXS is -29.98%
What is the all time high annual ROE for Astria Therapeutics?
Astria Therapeutics all-time high annual return on equity is 34.72%
What is Astria Therapeutics annual ROE year-on-year change?
Over the past year, ATXS annual return on equity has changed by -6.55% (-27.96%)
What is Astria Therapeutics quarterly return on equity?
The current quarterly ROE of ATXS is -30.79%
What is the all time high quarterly ROE for Astria Therapeutics?
Astria Therapeutics all-time high quarterly return on equity is 80.29%
What is Astria Therapeutics quarterly ROE year-on-year change?
Over the past year, ATXS quarterly return on equity has changed by -4.00% (-14.93%)